Trial intelligence / Profile preview

Automated pupillometry and NIRS-EEG to detect signatures of consciousness in disorders of consciousness

2021-001453-31Phase 2Completed

Sponsor
Copenhagen University Hospital Rigshospitalet
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in disorder of consciousness (DOC) comparing Methylphenidate sequence, Apomorphine sequence and Placebo sequence (3 arms). Primary endpoint: Primary endpoint 1. Started Mar 2021; status: completed.

02

Drugs

methylphenidateapomorphine
03

Conditions

disorder of consciousness (DOC)

Beyond the preview

Go deeper on 2021-001453-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-001453-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call